CLINICAL_TRIALS
trial_result
· 2008-03-20
Clinical Trial Update: Docetaxel in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Summary
A Phase 2 trial of docetaxel in non-small cell lung cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED